Navigating 4 Analyst Ratings For LeMaitre Vascular
Navigating 4 Analyst Ratings For LeMaitre Vascular
瀏覽 LeMaitre Vascular 的 4 個分析師評級
LeMaitre Vascular (NASDAQ:LMAT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師對LeMaitre Vascular（納斯達克股票代碼：LMAT）進行了分析，揭示了從看漲到看跌的不同觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $82.75, along with a high estimate of $100.00 and a low estimate of $75.00. This current average reflects an increase of 24.12% from the previous average price target of $66.67.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲82.75美元，最高估計爲100.00美元，低估值爲75.00美元。目前的平均價格比之前的66.67美元的平均目標股價上漲了24.12％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
A comprehensive examination of how financial experts...
對金融專家如何...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。